Inventor · disambiguated record
Jae Kap Jeong
Also filed as: JEONG JAE KAP
12 granted patents·7 pending applications·14 citations·filing 2007–2024
85Inventor score
Files withHANALL BIOPHARMA CO LTD9IMMUNOMET THERAPEUTICS INC4KIM SUNG WUK4KANG HYUN AH1KOREA RES INST OF BIOSCIENCE1
Top patents by PatentIndex Score
19 records- 0187US2025026835A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0284US10544226B2Antibody binding to FcRn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2015·Granted Jan 28, 2020·4 cites·21 claims
- 0384US2024092913A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0483US11613578B2Antibody binding to FCRN for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2019·Granted Mar 28, 2023·1 cites·23 claims
- 0583US10626085B2Biguanide compound and use thereofIMMUNOMET THERAPEUTICS INC·Filed 2015·Granted Apr 21, 2020·3 cites·7 claims
- 0681US2023235063A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0775US10336825B2Antibody binding to FcRn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2017·Granted Jul 2, 2019·1 cites·4 claims
- 0875US8236520B2Recombinant beta-galactosidase derived from Streptococcus pneumoniaeKANG HYUN AH·Filed 2010·Granted Aug 7, 2012·2 cites·4 claims
- 0973US10221190B2Biguanide compounds and use thereofIMMUNOMET THERAPEUTICS INC·Filed 2014·Granted Mar 5, 2019·2 cites·4 claims
- 1066US9068019B2Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameKIM SUNG WUK·Filed 2010·Granted Jun 30, 2015·1 cites·8 claims
- 1163US2019135917A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1259US11572341B2Biguanide compound and use thereofIMMUNOMET THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·5 claims
- 1356US2019144464A1Biguanide compounds and use thereofIMMUNOMET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1447US2008248019A1Recombinant beta-galactosidase derived from Streptococcus pneumaniaeKOREA RES INST OF BIOSCIENCE·Filed 2007·Application pending·0 cites
- 1544US10280207B2FcRn-specific human antibody and composition for treatment of autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2014·Granted May 7, 2019·0 cites·5 claims
- 1642US9580490B2Uses of modified human tumor necrosis factor receptor-1 polypeptideHANALL BIOPHARMA CO LTD·Filed 2013·Granted Feb 28, 2017·0 cites·13 claims
- 1741US8895500B2Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing sameKIM SUNG WUK·Filed 2011·Granted Nov 25, 2014·0 cites·18 claims
- 1841US2011294733A1Modified human thrombopoietin polypeptide fragment and manufacturing method thereofKIM SUNG WUK·Filed 2010·Application pending·0 cites
- 1939US8754037B2Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameKIM SUNG WUK·Filed 2011·Granted Jun 17, 2014·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Jae Kap Jeong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →